Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Amylin and Takeda enter into worldwide agreement for compounds for obesity

Nov. 4, 2009

Sosei enters definitive distribution agreement with Aska for contraceptive NorLevo

Nov. 4, 2009

Byetta approved for expanded use as first-line treatment for type 2 diabetes

Nov. 3, 2009

Human data available for anti-obesity drug PSN-602

Nov. 2, 2009

CP-8947, a novel nonsteroidal SPRM, exhibits progestational activity in preclinical study

Nov. 2, 2009

Kowa describes new LXRbeta agonists

Oct. 30, 2009

Ipsen's taspoglutide meets primary endpoint in Roche's first phase III trial in diabetes

Oct. 30, 2009

Yuhan Research Institute discovers glucokinase activator with antidiabetes potential

Oct. 30, 2009

Improved endothelial function seen with insulin VIAject in type 2 diabetes

Oct. 30, 2009

Meta-analyses describe the effects of liraglutide in type 2 diabetes

Oct. 30, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...